Collectively, these studies highlight a critical role for CXCR4 signaling in maintenance and progression of T-ALL in the BM TME, where the ligand CXCL12 is produced by endothelial cells. This evidence concerns the gene CXCR4 and acute lymphoblastic leukemia.